.png?width=474&height=175&name=ASH2024%20-Bannermarketing%20(1).png)
FOR IMMEDIATE RELEASE
Functional Fluidics Presents Sickle Cell Disease Data from U.S. and Nigeria at ASH Conference in San Diego on December 7-10, 2024
Detroit, Michigan and Awka, Nigeria – December 3, 2024 – Functional Fluidics, a leader in red blood cell health innovation, announces its participation in the upcoming American Society of Hematology (ASH) Annual Meeting and Exposition, taking place December 7-10, 2024, in San Diego, California.
The ASH annual meeting covers groundbreaking research, clinical advancements, and cutting-edge techniques. It brings together thousands of hematologists, researchers and healthcare professionals from around the globe to share knowledge, network, and collaborate on advancing the field of hematology.
Functional Fluidics will share real-world data during three poster presentations at the ASH conference. These presentations will feature two of the largest real-world population-scale studies of patients on voxelotor and crizanlizumab at US-based clinical sites and the first red blood cell health patient data generated in our new research facility in Awka, Nigeria.
Functional Fluidics Oral and Poster Abstracts
Title: 2305: Voxelotor Therapy Reduces Whole Blood Adhesion to VCAM-1 and P-Selectin, and Shows Modest Improvements in Self-Reported Pain in a Real-World Clinical Setting in a Multi-Center Retrospective Analysis
Session: 904. Outcomes Research: Hemoglobinopathies: Poster I
Hematology Disease Topics & Pathways:
Sickle Cell Disease, Hemoglobinopathies, Diseases
Date and Time: Saturday, December 7, 2024, 5:30PM - 7:30PM
Location: Halls G-H (San Diego Convention Center)
Presenter: Patrick Hines, MD/PhD, Founder and CEO, Functional Fluidics
Title: 3875: Further Validation of Flow Adhesion of Whole Blood to P-Selectin (FA-WB-PSEL) to Assess Targeted P-Selectin Therapies in Sickle Cell Disease (SCD)
Session: 113. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Basic and Translational: Poster III
Hematology Disease Topics & Pathways:
Research, Sickle Cell Disease, Translational Research, Hemoglobinopathies, Diseases
Date and Time: Monday, December 9, 2024, 6:00PM - 8:00PM
Location: Halls G-H (San Diego Convention Center)
Presenter: Jennell White PhD, Senior Scientist, Functional Fluidics
Title: 2250: Bridging the Gap for Sickle Cell Disease Patient Data in Sub-Saharan Africa By Expanding Access to Specialty Biomarkers and Clinical Trials
Session: 900. Health Services and Quality Improvement: Hemoglobinopathies: Poster I
Hematology Disease Topics & Pathways:
Research, Sickle Cell Disease, Translational Research, Hemoglobinopathies, Diseases, Biological Processes
Date and Time: Saturday, December 7, 2024, 5:30PM - 7:30PM
Location: Halls G-H (San Diego Convention Center)
Presenter: Nnamdi Okeke, PharmD, Vice President, Head of Global and Scientific Affairs, Functional Fluidics
"Functional Fluidics is excited to present our latest research at the ASH Annual Meeting, which remains the premier event for advancing the field of hematology," said Patrick Hines, Founder and CEO of Functional Fluidics. “Our work highlights the critical need for reliable objective tools to address the unmet needs in sickle cell disease, especially when it comes to monitoring patients in a real-world setting to improve their clinical outcome and positively impact their quality of life."
To learn more about our abstracts or attend a poster presentation at the ASH 2024 Annual Meeting visit ASH Conference Schedule.
About Functional Fluidics
Founded in 2014, Functional Fluidics is a global health technology company specializing in red blood cell health, that leverages healthcare data and technologies to accelerate the development of life-changing therapies, support clinical trials, and bridge the gap between clinical research and patient care. The company has locations in North America and Sub-Saharan Africa and partners with healthcare providers, researchers, and pharmaceutical organizations globally.
Founded in 2014, Functional Fluidics is a global health technology company specializing in red blood cell health, that leverages healthcare data and technologies to accelerate the development of life-changing therapies, support clinical trials, and bridge the gap between clinical research and patient care. The company has locations in North America and Sub-Saharan Africa and partners with healthcare providers, researchers, and pharmaceutical organizations globally.
For more information on our company, visit our website or follow us on our social media platforms.
Media Contact:
Nadine Russell, MBA
Global Business Director
Nadine Russell, MBA
Global Business Director
Functional Fluidics, Inc.
